Axhidrox (glycopyrronium bromide) pump-pack 2.2 mg/pump actuation cream

Axhidrox is the first anticholinergic licensed for the topical treatment of severe primary axillary hyperhidrosis in adults.

Axhidrox received a UK marketing authorisation in June 2025 and is expected to be available in the UK from May 2026.

The NHS list price is £69.50.

The Summary of Product Characteristics can be viewed here.

For further information on Axhidrox, please contact axunio

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to [email protected]